Ameriprise’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.7M | Sell |
3,240,058
-3,402,418
| -51% | -$39.6M | 0.01% | 1007 |
|
|
2025
Q1 | $49.4M | Buy |
6,642,476
+5,905,756
| +802% | +$43.9M | 0.01% | 845 |
|
|
2024
Q4 | $4.42M | Buy |
736,720
+654,309
| +794% | +$3.92M | ﹤0.01% | 2438 |
|
|
2024
Q3 | $422K | Buy |
82,411
+31,502
| +62% | +$161K | ﹤0.01% | 3531 |
|
|
2024
Q2 | $184K | Sell |
50,909
-795,470
| -94% | -$2.88M | ﹤0.01% | 3703 |
|
|
2024
Q1 | $2.72M | Buy |
846,379
+791,445
| +1,441% | +$2.54M | ﹤0.01% | 2716 |
|
|
2023
Q4 | $269K | Sell |
54,934
-24,685
| -31% | -$121K | ﹤0.01% | 3640 |
|
|
2023
Q3 | $434K | Buy |
79,619
+27,162
| +52% | +$148K | ﹤0.01% | 3459 |
|
|
2023
Q2 | $352K | Sell |
52,457
-375,507
| -88% | -$2.52M | ﹤0.01% | 3565 |
|
|
2023
Q1 | $3.78M | Buy |
427,964
+59,064
| +16% | +$522K | ﹤0.01% | 2504 |
|
|
2022
Q4 | $2.82M | Buy |
+368,900
| New | +$2.82M | ﹤0.01% | 2646 |
|
|
2022
Q2 | – | Sell |
-648,479
| Closed | -$9M | – | 3880 |
|
|
2022
Q1 | $9M | Buy |
648,479
+68,205
| +12% | +$947K | ﹤0.01% | 1998 |
|
|
2021
Q4 | $16.3M | Sell |
580,274
-226
| -0% | -$6.34K | ﹤0.01% | 1575 |
|
|
2021
Q3 | $19.7M | Buy |
580,500
+47,418
| +9% | +$1.61M | 0.01% | 1275 |
|
|
2021
Q2 | $21.8M | Sell |
533,082
-319,950
| -38% | -$13.1M | 0.01% | 1282 |
|
|
2021
Q1 | $34.3M | Buy |
853,032
+97,490
| +13% | +$3.92M | 0.01% | 960 |
|
|
2020
Q4 | $44.7M | Buy |
755,542
+164,134
| +28% | +$9.71M | 0.02% | 786 |
|
|
2020
Q3 | $28.8M | Buy |
591,408
+246,292
| +71% | +$12M | 0.01% | 888 |
|
|
2020
Q2 | $16.7M | Buy |
345,116
+12,445
| +4% | +$602K | 0.01% | 1167 |
|
|
2020
Q1 | $9.24M | Buy |
332,671
+45,813
| +16% | +$1.27M | ﹤0.01% | 1447 |
|
|
2019
Q4 | $8.58M | Buy |
286,858
+34,256
| +14% | +$1.02M | ﹤0.01% | 1866 |
|
|
2019
Q3 | $7.81M | Buy |
252,602
+92,005
| +57% | +$2.84M | ﹤0.01% | 1887 |
|
|
2019
Q2 | $7.76M | Buy |
+160,597
| New | +$7.76M | ﹤0.01% | 1917 |
|